Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

被引:59
作者
Tian, Yuejun [1 ]
Ma, Zhiming [1 ]
Chen, Zhaohui [1 ]
Li, Mingguo [1 ]
Wu, Zhiping [2 ]
Hong, Mei [1 ]
Wang, Hanzhang [3 ]
Svatek, Robert [3 ]
Rodriguez, Ronald [3 ]
Wang, Zhiping [1 ]
机构
[1] Lanzhou Univ, Hosp 2, Clin Ctr Gansu Prov Nephrourol, Key Lab Gansu Prov Urol Dis,Inst Urol, Lanzhou, Peoples R China
[2] Lanzhou Univ, Hosp 2, Dept Gastroenterol, Lanzhou, Peoples R China
[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA
来源
PLOS ONE | 2016年 / 11卷 / 07期
基金
中国国家自然科学基金; 美国国家科学基金会;
关键词
TRANSITIONAL-CELL CARCINOMA; TRANSURETHRAL RESECTION SPECIMENS; CYCLE REGULATORY PROTEINS; PREDICTIVE-VALUE; UROTHELIAL CARCINOMA; URINARY-BLADDER; LABELING INDEX; E-CADHERIN; PROGRESSION; SURVIVAL;
D O I
10.1371/journal.pone.0158891
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Ki-67 is an established marker of cell proliferation, and the Ki-67 index correlates with the clinical course of several cancer types, including bladder cancer (BC). However, the clinicopathological and prognostic significance of Ki-67 in bladder cancer remains unclear. Therefore, we performed a systematic review and meta-analysis to clarify this relationship. Methods A comprehensive literature search for relevant studies published up to February 1, 2016, was performed using PubMed, Cochrane Library, Embase and ISI Web of Knowledge. The effects of Ki-67 expression on survival outcome in patients with BC and BC subtypes were evaluated. Furthermore, the relationship between Ki-67 expression and the clinicopathological features of BC were assessed. Results Thirty-one studies with 5147 bladder cancer patients were selected for evaluation. Ki- 67 expression was significantly associated with shorter recurrence-free (HR 1.69, 95% CI: 1.33-2.14), progression- free (HR 1.89, 95% CI: 1.43-2.51), overall (HR 2.03, 95% CI: 1.31-3.16), and cancer-specific (HR 1.69, 95% CI: 1.47-1.95) survival. Moreover, whereas high expression was more common in high tumor stage, recurrence status, tumor size, there was no correlation between high Ki-67 expression and age, gender, smoking habits, and tumor number. Importantly, analysis of the different subgroups of BC suggested that significant correlations between high Ki-67 expression and survival outcome (recurrencefree/progression-free/overall/cancer-specificsurvival) are present only in European-American patients. Conclusion The present results indicate that over-expression of Ki-67 is distinctly correlated with poor patient survival. Ki-67 may serve as a valuable biomarker for prognosis in BC patients, particularly in non-Asian BC patients. The results suggest no significant association between Ki-67 expression and BC prognosis in Asian patients. Further efforts are needed to fully clarify this relationship.
引用
收藏
页数:14
相关论文
共 58 条
[1]  
Acikalin D, 2012, TUMORI, V98, P344, DOI 10.1700/1125.12403
[2]   Clinical model of lifetime cost of treating bladder cancer and associated complications [J].
Avritscher, Elenir B. C. ;
Cooksley, Catherine D. ;
Grossman, H. Barton ;
Sabichi, Anita L. ;
Hamblin, Lois ;
Dinney, Colin P. ;
Elting, Linda S. .
UROLOGY, 2006, 68 (03) :549-553
[3]   Expression of cell cycle-associated proteins in non-muscle-invasive bladder cancer: Correlation with intravesical recurrence following transurethral resection [J].
Behnsawy, Hosny M. ;
Miyake, Hideaki ;
Abdalla, Medhat A. ;
Sayed, Mohamed A. ;
Ahmed, Abd El-Fattah I. ;
Fujisawa, Masato .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2011, 29 (05) :495-501
[4]   Combination of CK20 and Ki-67 Immunostaining Analysis Predicts Recurrence, Progression, and Cancer-Specific Survival in pT1 Urothelial Bladder Cancer [J].
Bertz, Simone ;
Otto, Wolfgang ;
Denzinger, Stefan ;
Wieland, Wolf F. ;
Burger, Maximilian ;
Stoehr, Robert ;
Link, Stefan ;
Hofstaedter, Ferdinand ;
Hartmann, Arndt .
EUROPEAN UROLOGY, 2014, 65 (01) :218-226
[5]   Fascin is a predictor for invasiveness and recurrence of urothelial carcinoma of bladder [J].
Bi, Jianbin ;
Chen, Xuelei ;
Zhang, Yuxi ;
Li, Bingxun ;
Sun, Jiawei ;
Shen, Hailin ;
Kong, Chuize .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2012, 30 (05) :688-694
[6]   Biomarkers in bladder cancer [J].
Bryan, Richard T. ;
Zeegers, Maurice P. ;
James, Nicholas D. ;
Wallace, D. Michael A. ;
Cheng, Kar Keung .
BJU INTERNATIONAL, 2010, 105 (05) :608-613
[7]  
Chen JY, 2012, GUILTY OF INDIGENCE: THE URBAN POOR IN CHINA, 1900-1953, P13
[8]   Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma [J].
da Silva, Sabrina Daniela ;
Morand, Gregoire B. ;
Alobaid, Faisal A. ;
Hier, Michael P. ;
Mlynarek, Alex M. ;
Alaoui-Jamali, Moulay A. ;
Kowalski, Luiz Paulo .
CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (01) :55-63
[9]   Ki-67 is an independent indicator in non-muscle invasive bladder cancer (NMIBC); Combination of EORTC risk scores and Ki-67 expression could improve the risk stratification of NMIBC [J].
Ding Weihong ;
Gou, Yuancheng ;
Sun, Chuanyu ;
Xia, Guowei ;
Wang, Hong ;
Chen, Zhongqing ;
Tan, Jun ;
Xu, Ke ;
Ding, Qiang .
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) :42.e13-42.e19
[10]   Association Between Smoking and Risk of Bladder Cancer Among Men and Women [J].
Freedman, Neal D. ;
Silverman, Debra T. ;
Hollenbeck, Albert R. ;
Schatzkin, Arthur ;
Abnet, Christian C. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 306 (07) :737-745